NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models

Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Amyloid-β (Aβ) and hyper-phosphorylated tau accumulation are accountable for the progressive neuronal loss and cognitive impairments usually observed in AD. Currently, medications for AD offer moderate symptomat...

Full description

Bibliographic Details
Main Authors: Ashok Iyaswamy, Senthil Kumar Krishnamoorthi, Ju-Xian Song, Chuan-Bin Yang, Venkatapathy Kaliyamoorthy, Huan Zhang, Sravan G. Sreenivasmurthy, Sandeep Malampati, Zi-Ying Wang, Zhou Zhu, Benjamin Chun-Kit Tong, King-Ho Cheung, Jia-Hong Lu, Siva Sundara Kumar Durairajan, Min Li
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Journal of Food and Drug Analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S1021949819300882